Discussion Paper Details

Please find the details for DP15279 in an easy to copy and paste format below:

Full Details   |   Bibliographic Reference

Full Details

Title: Pricing above value: selling to an adverse selection market

Author(s): Jan Boone

Publication Date: September 2020

Keyword(s): Adverse Selection, pharmaceutical prices, pricing above value, risk equalization and Vertical Relations

Programme Area(s): Industrial Organization and Public Economics

Abstract: This paper shows that it is possible for intermediate goods to be priced above the value that the good has for final consumers. This happens in sectors selling to adverse selection markets where the cost difference between consumer types is dominated by their elasticity difference. High input prices then help to separate consumer types. An increase in competition can raise prices further. We use the example of pharmaceutical companies selling drugs to a health insurance market at prices exceeding value. Another feature of the model is an excessive private incentive to reduce market size, e.g. in the form of personalized medicine.

For full details and related downloads, please visit:

Bibliographic Reference

Boone, J. 2020. 'Pricing above value: selling to an adverse selection market'. London, Centre for Economic Policy Research.